Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

335 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dissimilar Effect of P-Glycoprotein and Breast Cancer Resistance Protein Inhibition on the Distribution of Erlotinib to the Retina and Brain in Humans and Mice.
Biali ME, Auvity S, Cisternino S, Smirnova M, Hacker M, Zeitlinger M, Mairinger S, Tournier N, Bauer M, Langer O. Biali ME, et al. Among authors: zeitlinger m. Mol Pharm. 2023 Nov 6;20(11):5877-5887. doi: 10.1021/acs.molpharmaceut.3c00715. Epub 2023 Oct 26. Mol Pharm. 2023. PMID: 37883694 Free PMC article.
[18F]Ciprofloxacin, a new positron emission tomography tracer for noninvasive assessment of the tissue distribution and pharmacokinetics of ciprofloxacin in humans.
Brunner M, Langer O, Dobrozemsky G, Müller U, Zeitlinger M, Mitterhauser M, Wadsak W, Dudczak R, Kletter K, Müller M. Brunner M, et al. Among authors: zeitlinger m. Antimicrob Agents Chemother. 2004 Oct;48(10):3850-7. doi: 10.1128/AAC.48.10.3850-3857.2004. Antimicrob Agents Chemother. 2004. PMID: 15388445 Free PMC article. Clinical Trial.
In vitro and in vivo evaluation of [18F]ciprofloxacin for the imaging of bacterial infections with PET.
Langer O, Brunner M, Zeitlinger M, Ziegler S, Müller U, Dobrozemsky G, Lackner E, Joukhadar C, Mitterhauser M, Wadsak W, Minar E, Dudczak R, Kletter K, Müller M. Langer O, et al. Among authors: zeitlinger m. Eur J Nucl Med Mol Imaging. 2005 Feb;32(2):143-50. doi: 10.1007/s00259-004-1646-2. Epub 2004 Sep 4. Eur J Nucl Med Mol Imaging. 2005. PMID: 15690222 Clinical Trial.
Age dependency of cerebral P-gp function measured with (R)-[11C]verapamil and PET.
Bauer M, Karch R, Neumann F, Abrahim A, Wagner CC, Kletter K, Müller M, Zeitlinger M, Langer O. Bauer M, et al. Among authors: zeitlinger m. Eur J Clin Pharmacol. 2009 Sep;65(9):941-6. doi: 10.1007/s00228-009-0709-5. Epub 2009 Aug 5. Eur J Clin Pharmacol. 2009. PMID: 19655132 Free PMC article.
A pilot study to assess the efficacy of tariquidar to inhibit P-glycoprotein at the human blood-brain barrier with (R)-11C-verapamil and PET.
Wagner CC, Bauer M, Karch R, Feurstein T, Kopp S, Chiba P, Kletter K, Löscher W, Müller M, Zeitlinger M, Langer O. Wagner CC, et al. Among authors: zeitlinger m. J Nucl Med. 2009 Dec;50(12):1954-61. doi: 10.2967/jnumed.109.063289. Epub 2009 Nov 12. J Nucl Med. 2009. PMID: 19910428 Free PMC article. Clinical Trial.
A combined accelerator mass spectrometry-positron emission tomography human microdose study with 14C- and 11C-labelled verapamil.
Wagner CC, Simpson M, Zeitlinger M, Bauer M, Karch R, Abrahim A, Feurstein T, Schütz M, Kletter K, Müller M, Lappin G, Langer O. Wagner CC, et al. Among authors: zeitlinger m. Clin Pharmacokinet. 2011 Feb;50(2):111-20. doi: 10.2165/11537250-000000000-00000. Clin Pharmacokinet. 2011. PMID: 21142292 Free PMC article. Clinical Trial.
335 results